During July to September 2022, 96.4% had SARS-CoV-2 antibodies, including 26.1% from vaccination alone, 22.6% from infection alone, and 47.7% from both.
.
During July to September 2022, 96.4% had SARS-CoV-2 antibodies, including 26.1% from vaccination alone, 22.6% from infection alone, and 47.7% from both.